Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

Richard Lewis Easeman has worked on the following 1 EPO patent applications which have been published in the last five years:

EP12700019

LIGANDS THAT BIND TGF-BETA RECEPTOR II

IPC classification:
C07K 16/28
Applicant:
Glaxo Group Limited
Agent:
Richard Lewis Easeman, GlaxoSmithKline
Status:
PATENT GRANTED

Please Sign in to use this feature